Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026)
Leef Brands (LEEEF) reported Depreciation & Amortization (CF) of $568141.0 for Q1 2026, up 6.15% on a YoY basis from $535237.0 in Q1 2025, and up 6.15% sequentially from $535237.0 in Q1 2025.
Leef Brands (LEEEF) Depreciation & Amortization (CF) (2025 - 2026) Analysis & Trends
Leef Brands (LEEEF) has 2 years of Depreciation & Amortization (CF) data on file, last reported at $568141.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 6.15% year-over-year to $568141.0; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed N/A YoY), and the FY2025 full-year result was $2.3 million, up 21.44% from the prior year.
- Depreciation & Amortization (CF) grew to $568141.0 in Q1 2026, from $535237.0 in the prior quarter.
- In the past five years, Depreciation & Amortization (CF) ranged from a high of $568141.0 in Q1 2026 to a low of $535237.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 239.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 119.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 1.04 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 22.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 676.10 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 172.00 Mn |
| 10 | Leef Brands | 51.94 Mn | 46.18 Mn | 4.62 Mn | 568,141.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2026 | 568,141.00 |
| Mar 31, 2025 | 535,237.00 |
| Mar 31, 2025 | 535,237.00 |